Tetraphase Pharmaceuticals misses by $0.03, misses on revenues

|About: Tetraphase Pharmaceuticals (TTPH)|By:, SA News Editor

Tetraphase Pharmaceuticals (TTPH): Q4 EPS of -$0.49 misses by $0.03.

Revenue of $1.9M misses by $0.2M.